Cleared Abbreviated

K040654 - SENSILASE PAD 3000

K040654 is an FDA 510(k) clearance for SENSILASE PAD 3000, manufactured by Optical Sensors, Inc.. The device is a Class 2 Cardiovascular device with product code DPW cleared through the Abbreviated 510(k) pathway after a 84-day FDA review.

K040654 · Optical Sensors, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2004
Decision
84d
Days
Class 2
Risk

K040654 is an FDA 510(k) clearance for the SENSILASE PAD 3000. Classified as Flowmeter, Blood, Cardiovascular (product code DPW), Class II - Special Controls.

Submitted by Optical Sensors, Inc. (Stoughton, US). The FDA issued a Cleared decision on June 4, 2004 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2100 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

FDA 510(k) Submission Details - K040654

510(k) Number K040654 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 12, 2004
Decision Date June 04, 2004
Days to Decision 84 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 125d · This submission: 84d
Pathway characteristics
Standards-based clearance path.

DPW Device Classification - Class 2, Special Controls

Product Code DPW Flowmeter, Blood, Cardiovascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPW Flowmeter, Blood, Cardiovascular

All 137
Devices cleared under the same product code (DPW) and FDA review panel - the closest regulatory comparables to K040654.
SMARTDOP 45 VASCULAR DOPPLER
K050601 · Koven Technology, Inc. · Apr 2005
QUANTIX/OR BLOOD FLOW MONITOR
K050088 · Neoprobe Corp. · Feb 2005
QUANTIX OR VESSEL STABILIZER DEVICE
K041180 · Cardiosonix, Ltd. · Jun 2004
MEDI-STIM VERIQ SYSTEM, MODEL VQ1001 - VQ4122
K040228 · Medi-Stim A/S · Apr 2004
SONO TT ULTRASONIC FLOWCOMPUTER
K040909 · Em-Tec GmbH · Apr 2004
ECHO SOUNDER EX-101EX 8 MHZ
K031931 · Koven Technology, Inc. · Feb 2004
K040654 · SENSILASE PAD 3000
Download PDF FDA Summary Optical Sensors, Inc.